2022年全球食品替代蛋白质政策报告（英文版）-GFI_73页_1mb

Summary of GFI's State of Global Policy Report: Public Investment in Alternative Proteins to Feed a Growing World

Core Content

This report provides an overview of global public investment and policy developments in the alternative protein sector as of the end of 2022, with some highlights from the first half of 2023. It emphasizes the growing recognition of alternative proteins as a critical solution for global food security, climate change mitigation, and economic development.

Key Findings

• Public Investment Surge: Governments worldwide more than doubled their financial support for alternative proteins in 2022, with an estimated $635 million in public funding, including $180 million for R&D, $290 million for commercialization, and $165 million for mixed initiatives. This likely brought total global public support to over $1 billion.
• Regulatory Progress: The U.S. became the second country after Singapore to complete a premarket consultation for cultivated meat. Singapore also approved multiple new products, including "protein from thin air" by Solar Foods. Israel granted regulatory approval for its first precision fermentation-derived animal protein.
• Labeling Restrictions: Several countries, including India, Canada, the EU, and some U.S. states, have implemented labeling restrictions on alternative proteins. These restrictions, however, have faced legal challenges or temporary suspensions. Türkiye banned plant-based cheese, while France temporarily instituted and then overturned two additional labeling restrictions.
• Legislative Actions: Over 100 nations signed the Global Methane Pledge at COP26, and alternative proteins were highlighted as a means to reduce emissions from food systems. At COP27, food production was a focus, with GFI co-hosting a pavilion and Singapore showcasing cultivated meat globally.
• Economic Potential: A Global Innovation Needs Assessment suggests that the alternative protein sector could support 9.8 million jobs and $1.1 trillion in economic value by 2050, but only if governments invest $4.4 billion annually in R&D and $5.7 billion in commercialization.

Main Views

• Global Collaboration Needed: To fully realize the potential of alternative proteins, governments must collaborate to meet the $10.1 billion annual investment target.
• Regulatory Clarity Crucial: Governments should ensure the safety and fair labeling of alternative proteins without imposing undue costs on producers or consumers.
• Diverse Strategies: Countries are adopting varied approaches to support alternative proteins, ranging from R&D funding to infrastructure development and commercialization support.

Key Information

• Public Investment Breakdown:
  • R&D: ~$180 million
  • Commercialization: ~$290 million
  • Mixed Initiatives: ~$165 million
• Notable Investments:
  • Singapore: SGD 144 million in 2020, added SGD 165 million in 2022 for the Singapore Food Story R&D Programme.
  • Denmark: DKK 675 million (~$99.4 million) for plant-based food development.
  • Netherlands: €60 million (~$66.2 million) to build a full cellular agriculture ecosystem.
  • Israel: $26 million in alternative protein research and infrastructure, including an $18 million cultivated meat consortium.
  • Finland: €34 million (~$37.3 million) for a hydrogen-based edible protein startup.
  • France: €30 million for plant-based protein research and €10.4 million to help a plant-based meat producer retrofit facilities.
  • Oman: Invested in a facility to convert excess dates into feedstock for biomass fermentation.
  • Australia: AUD 113 million (~$74.6 million) to build three plant protein facilities.
  • Canada: CAD 173 million (~$127 million) in public funding for 55 projects, including CAD 1.6 million for a Regulatory Centre of Excellence.

Country Updates

Brazil

• Public Support: Committed public funds for the first time in 2022, with FINEP pledging $500,000 for alternative protein research. Paraná allocated $808,000 for a cultivated meat lab at the Federal University of Paraná.
• Regulation: ANVISA is analyzing the regulatory landscape, and the Institute of Food Technology completed regulatory studies on plant-based products. Brazil issued a decree to zero out a sales tax on plant-based milks, equalizing them with traditional dairy products.
• Industry Involvement: JBS, the world's largest meat company, invested in cultivated meat and deforestation reduction efforts.

Canada

• Public Support: Protein Industries Canada (PIC) invested CAD 173 million in 55 projects, including CAD 1.4 million for tofu production and CAD 5.4 million for plant-based cheese development.
• Regulation: Cultivated meat and seafood are classified as novel foods, requiring detailed safety and environmental assessments. PIC is developing a virtual regulatory resource for plant-based companies.

United States

• Regulatory Milestone: FDA completed its first premarket consultation for cultivated chicken, clearing the path for 2023 sales.
• Market Leadership: The U.S. leads in the alternative protein market, with both domestic and international companies expanding operations. The Biden administration's executive order on biotechnology aims to boost innovation in new food sources.

Conclusion

The alternative protein sector is gaining momentum globally, with significant public investment and regulatory progress. However, more funding and policy coordination are needed to ensure the sector's full potential in addressing food security, climate change, and economic growth. The report highlights the importance of government support in scaling up the industry and fostering innovation.